CHARTING THE PATH TO
Magellan Bioanalytics has developed proprietary AI software for analyzing rich mass spectrometry data. We aim to find serum biomarkers that can improve precision medicine.
No other proteomics company is analyzing data at Magellan's scale. While other companies measure a few thousand proteins, our software analyzes >2.5M proteins, peptides, and peptide fragments circulating in serum. These biomolecules are present due to ongoing cellular processes and dynamically reflect the current health of the individual.
Our internal research centers on developing a biomarker database of cancer patients, with a goal of commercializing the data through partnerships